Teladoc Health (NYSE:TDOC) CEO Sells $108,610.50 in Stock

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) CEO Charles III sold 17,805 shares of the business’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $6.10, for a total transaction of $108,610.50. Following the transaction, the chief executive officer owned 465,535 shares of the company’s stock, valued at approximately $2,839,763.50. The trade was a 3.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Teladoc Health Price Performance

Teladoc Health stock opened at $6.43 on Thursday. Teladoc Health, Inc. has a 1-year low of $4.40 and a 1-year high of $9.89. The stock has a market cap of $1.17 billion, a PE ratio of -6.50 and a beta of 2.12. The stock’s fifty day moving average is $7.35 and its two-hundred day moving average is $6.80.

Teladoc Health (NYSE:TDOCGet Free Report) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business had revenue of $606.93 million during the quarter, compared to analysts’ expectations of $615.44 million. During the same period in the prior year, the firm posted ($0.19) EPS. The business’s quarterly revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, research analysts expect that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Allworth Financial LP purchased a new position in Teladoc Health in the 2nd quarter valued at approximately $25,000. Twin Lakes Capital Management LLC purchased a new stake in Teladoc Health during the second quarter worth $26,000. Nykredit A S acquired a new stake in Teladoc Health in the second quarter valued at $27,000. EFG International AG acquired a new stake in Teladoc Health in the second quarter valued at $35,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in Teladoc Health in the second quarter valued at $46,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several recent analyst reports. Bank of America increased their price target on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Finally, Citigroup dropped their target price on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd. Five investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $7.54.

View Our Latest Research Report on TDOC

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company’s offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.

See Also

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.